Back to search

Article

Adverse event analysis and signal detection of calcitonin gene-related peptide inhibitors using the FDA Adverse Event Reporting System database

2024-07-19

Abstract excerpt

<title>Abstract</title> <p>Background Calcitonin gene-related peptide (CGRP) inhibitors have been FDA-approved for migraine prophylaxis and relief. However, their safety profile remains uncertain. This study analyzes adverse events (AEs) and signals of disproportionate reporting (SDRs) using the FDA Adverse Event Reporting System (FAERS). Methods We examined AEs reported to FAERS from the approval date to Augus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
daab0b83-8f6e-50e0-965b-56953ad1451f
DOI
10.21203/rs.3.rs-4628990/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Adverse event analysis and signal detection of calcitonin gene-related peptide inhibitors using the FDA Adverse Event Reporting System databaseDOI 10.21203/rs.3.rs-4628990/v1
Select a neighboring publication to make it the new centre.